๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Immunotherapy
Clinical trial register · China

Immunotherapy Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 3 Fuzhou 1 Huizhou 1 Jieyang 1 Meizhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou3 Fuzhou1 Huizhou1 Jieyang1 Meizhou1
All 6 locations
Target enrolment
to

Immunotherapy trials in China

4 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
NCT07436845Hepatocellular Carcinoma (HCC), Emotional Distress, HAIC(Hepatic Artery Infusion Chemotherapy), Immunotherapy
Nanfang Hospital, Southern Medical University
Observational
90
Guangzhou
2025-12-01
Active, closed
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
NCT07230080HCC - Hepatocellular Carcinoma, SBRT, TACE, Immunotherapy
Nanfang Hospital, Southern Medical University
Observational
17
Guangzhou
2024-09-01
Recruiting
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
NCT06276088Immunotherapy, Hyperprogression, Biomarker
Nanfang Hospital, Southern Medical University
Observational
374
Guangzhou, Fuzhou, Huizhou, Jieyang, Meizhou
2024-02-18
Recruiting
Adjuvant Chemotherapy Combined With Camrelizumab for โ…กA -โ…ขA NSCLC Patients
NCT05825443Immunotherapy, Chemotherapy
Nanfang Hospital, Southern Medical University
Phase 2
57
Guandong
2023-04-10
Rows per page Showing 1–4 of 4
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/condition/immunotherapy

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 4 of those studies listing the condition Immunotherapy that also match the filters currently applied.

How many Immunotherapy trials are recruiting in China?

3 of the 4 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Immunotherapy), 4 studies
PhaseStudiesRecruitingShare
Observational3275%
Phase 21125%

Most active sponsors

Lead sponsors with the most studies (Immunotherapy)
Lead sponsorStudiesRecruiting
Nanfang Hospital, Southern Medical University43
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.